A hormone called GLP-1 has long been thought to have a positive impact on beta cell survival, and now scientists have started to uncover how it works. The new findings provide scientists with insights to improve the effects of currently available drugs that may prevent beta cell loss and promote beta cell survival in people with T1D or in those in the transplant setting.
JDRF studies provided new insight into the biological mechanisms that govern beta cell development, growth, and survival. As a result, they point to new approaches to produce or regenerate insulin-producing cells to cure the disease.
JDRF-funded researchers have identified a key signal that prompts existing beta cells, the only cells in the body that produce the hormone insulin, to form new beta cells. Their breakthrough discovery may ultimately be used to develop new treatments that will help to increase the number or function of beta cells in people with type […]